When the product accumulates beyond an optimal amount it binds to a site (ALLOSTERICsite) on the enzyme, changing the shape so that it can no longer react with its substrate.
Studies have shown that protease molecule with two non-active site binding groove (allostericsite), can be used to develop drug resistance against HIV, the new strategy.